ARCHIVES

Adjuvant XELOX More Effective Than 5-FU/LV For Stage III Colon Cancer

This article is from The Cancer Letter archive.

Vol. 33 No. 1 | January 29, 2010

Download PDF Visit The Full Archive

Related Articles

Conference Split Difference, NCI Gets $1.075 Billion

October 21, 1983

NCI’s Justification For 1981 Budget

June 8, 1979

St. Jude Director Cites Poor Housing’s Toll on Children, March 28, 1971

May 19, 2021

Panel Calls For New Office, Advisory Groups To Oversee NCI’s Translational Research.

June 22, 2007

In Brief: King ACCC President, Fleming President Elect; Wyngaarden Says He Doesn’t Oppose Panel

March 25, 1988

Moloney Convinces Most NCAB Members Of Virus Program Value, Shubik Only Dissenter

October 15, 1976